companies

Gleamer

Founded 2017
Employees 50+
Primary contact
5 avenue du Général de Gaulle
94160 Saint Mandé
Île-de-France
France
Links
https://www.gleamer.ai/
Sections
Technologies
Gleamer is developing AI-powered solutions supporting radiologists and clinicians in their diagnoses, thereby improving reliability and reducing the time taken to read and process examinations. Its products include BoneView for detecting bone trauma lesions, ChestView for detecting pulmonary pathologies, BoneMeasurement for automating MSK measurements, and BoneAge for automating bone age estimation. All four solutions hold MDR class IIa CE certification in Europe. BoneView has also received FDA clearance for use in adults and children over the age of two, making it the first and only AI-powered solution certified for detecting bone fractures in adults and children in the United States.
Select partners: Imagerie Medicale du Parc Lyon (IMPL), Ferrum Health, Fujifilm, RMS Medical Devices, AIDOC, VIDI, Wellbeing Software, DATAMED, Philips, Sectra, Blackford.
Founded 2017
Employees 50+
Primary contact
5 avenue du Général de Gaulle
94160 Saint Mandé
Île-de-France
France
Links
https://www.gleamer.ai/
Sections
Technologies

Funding 💰

Total €36M
Last round 🔗 €27M
Series B
June 28, 2023.
Select investors Supernova Invest, Heal Capital, XAnge, Bpifrance, Elaia, MACSF, UI Investissement, Crista Galli Ventures

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • BoneView Measurements: The Boneview Measurements automates the daily measurements and ease interpretation thanks to its easy-to-read display. It works on standard X-ray radiographs and EOS images for different anatomical areas: pelvis, legs, foot, and spine. 🔗
  • BoneView Bone Age: The Boneview Bone Age algorithm automates bone age assessment using the Greulich & Pyle atlas method, saving valuable time while ensuring precision. The user-friendly summary table streamlines the process and enhances clinician satisfaction, optimizing workflow and improving patient outcomes. 🔗
  • BoneView FDA & BoneView Trauma: These solutions provide radiologists and ED doctors with an instant and automatic 2nd reading of trauma X-Rays fully integrated into the reading workflow. 🔗
  • ChestView: ChestView AI provides radiologists and clinicians with an instant and automatic 2nd reading of Chest X-Rays fully integrated in the reading workflow. It aims to drastically increase sensitivity to detect subtle abnormalities. One of the immediate benefits would be to detect potential signs of cancer much earlier. 🔗

Video ▶️

Awards & Recognitions 🏆

  • 2023 Among TOP 24 European Tech Companies
  • 2023 EuroMinnies Awards: Best New Radiology Vendor 🔗
  • 2022 Alexander R. Margulis Award for Scientific Excellence

Quotes 💬

“
Gleamer is positioned as a leader in the use of AI in radiology, with a catalog of solutions to improve the diagnosis of numerous pathologies and the effectiveness of care, for the benefit of patients. Supernova Invest is delighted to support a visionary team with unique growth potential, redefining the contours of radiology and medical imaging through disruptive technological solutions that can be deployed on a large scale. This is a company whose business and societal models, and technological challenges are in line with Supernova Invest's DNA.
— Rémi Spagnol, Investment Director at Supernova Invest 🔗
“
We look for investments that meet a critical market need and Gleamer is the perfect example of a company that will make an impact as it is poised to become a leader in AI-powered medical solutions and continues to innovate and advance the field of medical AI.
— Christian Lautner, Founding Managing Partner, Heal Capital 🔗
Last update: July 4, 2023